Pliant Therapeutics (PLRX) Change in Receivables (2020 - 2023)
Pliant Therapeutics (PLRX) reported Change in Receivables of -$1.6 million for Q3 2023, up 54.95% year-over-year from -$1.0 million in Q3 2022, and up 7.98% quarter-over-quarter from -$1.7 million in Q2 2023.
Pliant Therapeutics (PLRX) Change in Receivables (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has 4 years of Change in Receivables data on file, last reported at -$1.6 million in Q3 2023.
- Change in Receivables for Q3 2023 came in at -$1.6 million, up 54.95% year-over-year; the trailing twelve-month figure through Jun 2024 was -$1.6 million (up 53.65% YoY), and the FY2023 annual result was -$2.0 million, down 13120.0% from the prior year.
- Change in Receivables rose to -$1.6 million in Q3 2023 per PLRX's latest filing, from -$1.7 million in the prior quarter.
- Over five years, Change in Receivables peaked at $24.7 million in Q1 2020 and troughed at -$28.2 million in Q2 2020.
- A 4-year average of -$470133.3 and a median of -$220000.0 in 2021 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 1187.21% in 2022 and fell as far as 1494.09% in 2022.
- A 4-year view of Change in Receivables shows it stood at $2.1 million in 2020, then slumped by 81.94% to $388000.0 in 2021, then grew by 29.12% to $501000.0 in 2022, then slumped by 415.37% to -$1.6 million in 2023.
- Business Quant data shows PLRX's Change in Receivables at -$1.6 million in Q3 2023, -$1.7 million in Q2 2023, and $1.3 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -1.58 Mn |
| Sep 30, 2023 | -1.58 Mn |
| Jun 30, 2023 | -1.72 Mn |
| Jun 30, 2023 | -1.72 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 501,000.00 |
| Dec 31, 2022 | 501,000.00 |
| Sep 30, 2022 | -3.51 Mn |
| Sep 30, 2022 | -3.51 Mn |
| Jun 30, 2022 | 3.74 Mn |
| Jun 30, 2022 | 3.74 Mn |
| Mar 31, 2022 | -749,000.00 |
| Mar 31, 2022 | -749,000.00 |
| Dec 31, 2021 | 388,000.00 |
| Dec 31, 2021 | 388,000.00 |
| Sep 30, 2021 | -220,000.00 |
| Sep 30, 2021 | -220,000.00 |
| Jun 30, 2021 | -344,000.00 |
| Jun 30, 2021 | -344,000.00 |